Different effects of levodopa and subthalamic stimulation on emotional conflict in Parkinson's disease

Hum Brain Mapp. 2018 Dec;39(12):5014-5027. doi: 10.1002/hbm.24341. Epub 2018 Sep 26.


Parkinson's disease impairs the decoding of emotional stimuli reflecting alterations of the limbic cortico-subcortical network. The objective of this study was to assess and compare the behavioral and electrophysiological effects of both levodopa and subthalamic stimulation on emotional processing in Parkinson's disease. Operated patients (n =16) and matched healthy subjects performed an emotional Stroop task, in which the emotion expressed by a face must be recognized while ignoring an emotional distractive word and that includes a neutral control sub-task. Patients were tested in the four possible treatment conditions (off stim/off med; on stim/off med; off stim/on med; and on stim/on med). High-resolution electroencephalography was recorded while performing the task. Patients made significantly more mistakes in facial emotion recognition than healthy subjects (p < .005). Untreated patients performed worse in the emotional trials than in the control sub-task (p < .05). Fearful faces induced significantly slower reaction times than happy faces in patients (p = .0002), but not in the healthy subjects. The emotional Stroop effect with levodopa was significantly higher than with subthalamic stimulation when fearful faces were assessed (p = .0243). Conversely, treatments did not modulate the Stroop effect of the control sub-task. EEG demonstrated that, compared with the untreated state, levodopa but not subthalamic stimulation significantly increases the amplitude of the event-related potential N170 (p = .002 vs. p = .1, respectively), an electrophysiological biomarker of early aspects of facial processing. The activity of the N170 cortical sources within the right fusiform gyrus was increased by levodopa (p < .05) but not by stimulation. While levodopa normalizes the recognition of emotional facial expression and early EEG markers of emotional processing, subthalamic stimulation does not. Thus, operated patients require dopaminergic medication in addition to stimulation to treat emotional symptoms of Parkinson's disease.

Keywords: Parkinson's disease; electroencephalogram; emotional Stroop; emotional conflict; levodopa; subthalamic deep brain stimulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antiparkinson Agents / pharmacology*
  • Cerebral Cortex / physiopathology*
  • Deep Brain Stimulation / methods*
  • Electroencephalography / methods*
  • Emotions / physiology*
  • Evoked Potentials / physiology*
  • Facial Expression*
  • Facial Recognition / physiology*
  • Female
  • Humans
  • Levodopa / pharmacology*
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology*
  • Parkinson Disease / therapy*
  • Stroop Test
  • Subthalamic Nucleus*
  • Treatment Outcome


  • Antiparkinson Agents
  • Levodopa